TRAVERE THERAPEUTICS, INC.
TVTX · NASDAQ
Travere Therapeutics is a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, the company knows the need for treatment options is urgent - that is why its global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, Travere continuously seeks to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope - today and tomorrow.
Market Data
Price
$53.61
+1.57 (+3.02%)
Market Cap$4.64B
P/E Ratio—
EPS$—
52W High$52.72
52W Low$13.88
Beta1.12
Data from Finnhub · Updated Jun 15, 2026